Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cyclophosphamide and Topotecan in Pediatric Solid Tumors
NCT00628732Phase 2Completed
- Sponsor
- Children's Medical Center Dallas
- Start
- Jan 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan, cyclophosphamide in solid tumor, sponsored by Children's Medical Center Dallas. Started Jan 2005; status: completed.
02
Drugs
topotecancyclophosphamide
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00628732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628732.